Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer

被引：0
|
作者：
Zaoqu Liu
Taoyuan Lu
Jing Li
Libo Wang
Kaihao Xu
Qin Dang
Chunguang Guo
Long Liu
Dechao Jiao
Zhenqiang Sun
Xinwei Han
机构：
[1] The First Affiliated Hospital of Zhengzhou University,Department of Interventional Radiology
[2] Interventional Institute of Zhengzhou University,Department of Cerebrovascular Disease
[3] Interventional Treatment and Clinical Research Center of Henan Province,Department of Hepatobiliary and Pancreatic Surgery
[4] Zhengzhou University People’s Hospital,Department of Colorectal Surgery
[5] The First Affiliated Hospital of Zhengzhou University,Department of Endovascular Surgery
[6] The First Affiliated Hospital of Zhengzhou University,undefined
[7] The First Affiliated Hospital of Zhengzhou University,undefined
来源：
Cancer Cell International | / 21卷
关键词：
Stage II/III colorectal cancer; Recurrence; Gene signature; Adjuvant chemotherapy; LASSO;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Development and clinical validation of a novel six-gene signature for accurately predicting the recurrence risk of patients with stage II/III colorectal cancer
    Liu, Zaoqu
    Lu, Taoyuan
    Li, Jing
    Wang, Libo
    Xu, Kaihao
    Dang, Qin
    Guo, Chunguang
    Liu, Long
    Jiao, Dechao
    Sun, Zhenqiang
    Han, Xinwei
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [2] Development and validation of a novel six-gene signature to accurately risk stratify men with early-stage prostate cancer to aid in treatment decision making
    Krzyzanowska, A.
    Barron, S.
    Loughman, T.
    Higgins, D. F.
    Sheehan, K. M.
    Wang, A. Chan-Ju
    Fender, B.
    McGuire, L. M.
    O'Neill, A.
    Fay, J.
    O'Grady, T.
    O'Leary, D.
    Bjartell, A.
    Watson, R. W. G.
    Gallagher, W. M.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S1190 - S1190
  • [3] Development and Validation of a Six-Gene Recurrence Risk Score Assay for Gastric Cancer
    Lee, Keun-Wook
    Lee, Sung Sook
    Hwang, Jun-Eul
    Jang, Hee-Jin
    Lee, Hyun-Sung
    Oh, Sang Cheul
    Lee, Sang Ho
    Sohn, Bo Hwa
    Kim, Sang Bae
    Shim, Jae-Jun
    Jeong, Woojin
    Cha, Minse
    Cheong, Jae-Ho
    Cho, Jae Yong
    Lim, Jae Yun
    Park, Eun Sung
    Kim, Sang Cheol
    Kang, Yoon-Koo
    Noh, Sung Hoon
    Ajani, Jaffer A.
    Lee, Ju-Seog
    CLINICAL CANCER RESEARCH, 2016, 22 (24) : 6228 - 6235
  • [4] Development and Validation of a Six-Gene Prognostic Signature for Bladder Cancer
    Xu, Fei
    Tang, Qianqian
    Wang, Yejinpeng
    Wang, Gang
    Qian, Kaiyu
    Ju, Lingao
    Xiao, Yu
    FRONTIERS IN GENETICS, 2021, 12
  • [5] Development and Validation of a Prognostic Nine Gene Expression Signature for Stage II/III Colorectal Cancer Patients
    Cheng, Liang
    Wang, Lisha
    Shen, Xiaohan
    Ren, Fei
    Sheng, Weiqi
    Zhou, Xiaoyan
    Du, Xiang
    LABORATORY INVESTIGATION, 2016, 96 : 165A - 165A
  • [6] Development and Validation of a Prognostic Nine Gene Expression Signature for Stage II/III Colorectal Cancer Patients
    Cheng, Liang
    Wang, Lisha
    Shen, Xiaohan
    Ren, Fei
    Sheng, Weiqi
    Zhou, Xiaoyan
    Du, Xiang
    MODERN PATHOLOGY, 2016, 29 : 165A - 165A
  • [7] Development, Validation, and Clinical Utility of a Six-gene Signature to Predict Aggressive Prostate Cancer
    Krzyzanowska, Agnieszka
    Barron, Stephen
    Higgins, Debra F.
    Loughman, Tony
    O'Neill, Amanda
    Sheehan, Katherine M.
    Wang, Chan-Ju Angel
    Fender, Bozena
    McGuire, Leah
    Fay, Joanna
    O'Grady, Anthony
    O'Leary, Des
    Watson, R. William
    Bjartell, Anders
    Gallagher, William M.
    EUROPEAN UROLOGY FOCUS, 2023, 9 (06): : 983 - 991
  • [8] Development and validation of a six-gene signature for predicting prognosis in prostate cancer patients with lymph node metastasis.
    Guo, Jinan
    Xie, Wenzhuan
    Huang, Mengli
    Gao, Chan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] A Hallmark-Based Six-Gene Expression Signature to Assess Colorectal Cancer and Its Recurrence Risk
    Lu, Huiqi
    Tang, Ying
    Zong, Kevin
    Wang, Guanghui
    Wang, Zhewei
    Chen, Xi
    Han, Huanxing
    Liu, Derong
    Zong, Qin
    Cui, Long
    Yang, Yili
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2019, 23 (08) : 557 - 564
  • [10] Development and clinical validation of a novel biopsy-based six-gene signature to accurately risk-stratify men with early-stage prostate cancer to aid treatment decision making.
    Krzyzanowska, Agnieszka
    Barron, Stephen
    Higgins, Debra
    Loughman, Tony
    Sheehan, Katherine
    Wang, Angel Chan-Ju
    Fender, Bozena
    McGuire, Leah M.
    Galvin, David Jonathan
    O'Neill, Amanda
    Fay, Joanna
    O'Grady, Anthony
    O'Leary, Des
    Watson, William
    Bjartell, Anders
    Gallagher, William M.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
12345